Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CALX | Common Stock | Options Exercise | $149K | +25K | $5.95* | 25K | Dec 15, 2021 | Direct | F1 | |
transaction | CALX | Common Stock | Sale | -$1.62M | -25K | -100% | $64.72 | 0 | Dec 15, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CALX | Stock Option (right to buy) | Options Exercise | $0 | -25K | -50% | $0.00 | 25K | Dec 15, 2021 | Common Stock | 25K | $5.95 | Direct | F3 |
Id | Content |
---|---|
F1 | The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan |
F2 | Shares sold between $63.26 and $65.88 per share at a weighted average price of $64.72. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. |
F3 | 100% of the shares subject to the option grant were fully vested and exercisable on January 1, 2021. |